valeant pharmaceuticals inte
(VRX:Toronto)
Executive Profile*
Howard Bradley SchillerChief Financial Officer, Principal Accounting Officer, Executive Vice President and Director, Valeant Pharmaceuticals International, Inc. |
| Age | Total Calculated Compensation | This person is connected to 138 board members in 4 different organizations across 6 different industries. See Board Relationships |
| 50 | $6,715,711 As of Fiscal Year 2012 |
Background*
Mr. Howard Bradley Schiller has been an Executive Vice President and Chief Financial Officer of Valeant Pharmaceuticals International, Inc. since December 2011 and serves as its Principal Accounting Officer. Mr. Schiller has been Treasurer at Obagi Medical Products, Inc. since April 2013. He has been Chief Financial Officer, Executive Vice President, and Treasurer of Medicis Pharmaceutical Corp., since December 11, 2012. In January 2011, Mr. Schiller retired from Goldman ...
Corporate Headquarters*2150 St. Elzéar boulevard WestLaval, Quebec H7L 4A8 Canada Phone: 514-744-6792 Fax: 514-744-6272 Board Members Memberships*Trustee 2012-Present Chief Financial Officer, Executive Vice President, Treasurer, and Director 2012-Present Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Director 2013-Present Treasurer and Director
Education*BS University of Pennsylvania - The Wharton School JD University of Chicago Law School
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| VRX:CN | C$76.85 CAD | -0.81 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Paul M. Bisaro | Chief Executive Officer, President and Director Actavis, Inc. | $2.4M |
| Dilip Shantilal Shanghvi | Managing Director, Promoter executive Director and Member of Shareholders/Investors Grievance Committee Sun Pharmaceutical Industries Limited | -- |
| David E. I. Pyott | Chairman, Chief Executive Officer and President Allergan Inc. | $1.3M |
| Joseph C. Papa | Chairman, Chief Executive Officer and President Perrigo Company | $1.0M |
| Flemming Ornskov M.D., MBA, MPH | Chief Executive Officer, Head of Human Genetic Therapies and Director Shire plc | -- | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Bridgewater, NJ | Valeant Pharmaceuticals InternationalPosted: May 07
- Bridgewater, NJ | Valeant PharmaceuticalsPosted: May 21
- Bridgewater, NJ | Valeant Pharmaceuticals InternationalPosted: May 06
- Bridgewater, NJ | Valeant PharmaceuticalsPosted: May 17
Sponsored Financial Commentaries
Sponsored Links
To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
